Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China · Delayed Price · Currency is CNY 6.81
-0.08 (-1.16%)
May 28, 2026, 3:04 PM CST
SHE:000952 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -399.87 | -404.49 | -295.29 | -140.25 | 50.33 | 110.11 |
Depreciation & Amortization | 160.27 | 160.27 | 165.14 | 119.95 | 98.31 | 91.26 |
Other Amortization | 1.81 | 1.81 | 1.92 | 0.77 | 0.01 | 0.12 |
Loss (Gain) From Sale of Assets | -0.55 | -0.55 | 2.4 | -0.25 | 4.31 | -0.54 |
Asset Writedown & Restructuring Costs | 265.29 | 265.29 | 30.68 | 0.12 | 12.28 | 1.15 |
Loss (Gain) From Sale of Investments | -18.38 | -18.38 | 27.92 | 9.24 | -6.3 | -18.72 |
Provision & Write-off of Bad Debts | 7.28 | 7.28 | -2.8 | 0.14 | - | - |
Other Operating Activities | 72.92 | 44.19 | 47.8 | 46.89 | 14.12 | 13.91 |
Change in Accounts Receivable | -118.47 | -118.47 | 156.17 | -53.06 | -102.06 | -66.93 |
Change in Inventory | 47.79 | 47.79 | -14.16 | -100.18 | -64.33 | -4.35 |
Change in Accounts Payable | 90.63 | 90.63 | -114.2 | -44.87 | 29.87 | -47.38 |
Change in Other Net Operating Assets | -10.75 | -10.75 | 0.12 | 0.91 | 10.83 | - |
Operating Cash Flow | 93.79 | 60.43 | 0.66 | -148.96 | 45.08 | 75.91 |
Operating Cash Flow Growth | 94.12% | 9120.65% | - | - | -40.61% | -36.42% |
Capital Expenditures | -30.81 | -35.64 | -154.93 | -566.13 | -203.71 | -96.61 |
Sale of Property, Plant & Equipment | 6 | 5 | 2.16 | 0.35 | 0 | 0.74 |
Divestitures | 10.65 | 55.44 | - | - | - | - |
Investment in Securities | - | - | - | - | 80 | -20 |
Other Investing Activities | - | - | - | - | 1.97 | 1.76 |
Investing Cash Flow | -14.16 | 24.79 | -152.78 | -565.78 | -121.74 | -114.1 |
Short-Term Debt Issued | - | - | - | 20 | - | - |
Long-Term Debt Issued | - | 742.68 | 766.31 | 1,221 | 739.45 | 388.65 |
Total Debt Issued | 768.04 | 742.68 | 766.31 | 1,241 | 739.45 | 388.65 |
Long-Term Debt Repaid | - | -805.82 | -660.49 | -559.51 | -438.48 | -399.77 |
Total Debt Repaid | -892.62 | -805.82 | -660.49 | -559.51 | -438.48 | -399.77 |
Net Debt Issued (Repaid) | -124.58 | -63.13 | 105.82 | 681.09 | 300.97 | -11.12 |
Issuance of Common Stock | - | - | - | - | 36.19 | - |
Repurchase of Common Stock | -11.34 | -11.34 | -14.51 | -0.44 | - | - |
Common Dividends Paid | -49.78 | -50.95 | -50.46 | -31.56 | -40.24 | -35.65 |
Other Financing Activities | -0.35 | -0.01 | 2 | 52 | 4.02 | - |
Financing Cash Flow | -186.05 | -125.43 | 42.84 | 701.09 | 300.94 | -46.77 |
Foreign Exchange Rate Adjustments | -0.44 | 0.78 | 1.21 | 0.12 | 1.43 | -1.5 |
Net Cash Flow | -106.85 | -39.42 | -108.07 | -13.54 | 225.71 | -86.47 |
Free Cash Flow | 62.98 | 24.79 | -154.28 | -715.1 | -158.63 | -20.7 |
Free Cash Flow Margin | 9.86% | 3.97% | -24.15% | -96.92% | -19.89% | -2.63% |
Free Cash Flow Per Share | 0.18 | 0.07 | -0.44 | -2.02 | -0.45 | -0.06 |
Cash Income Tax Paid | 11.96 | 11.62 | -33.62 | 20.53 | 8.91 | 37.53 |
Levered Free Cash Flow | 283.12 | 224.68 | -71.87 | -515.16 | -137.81 | -64.25 |
Unlevered Free Cash Flow | 316.16 | 256.65 | -33.14 | -484.44 | -124.63 | -53.81 |
Change in Working Capital | 5.02 | 5.02 | 22.88 | -185.58 | -127.98 | -121.37 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.